TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 5, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 5
- +1 vs. Q2 2021
- Portfolio value
- $440.7M
- +$230.7M (+109.8%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 19,363,975 | $250.4M | 56.8% | +19,363,975 | New | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $66.1M | 15.0% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 6,758,204 | $49.2M | 11.2% | −1,250,000−15.6% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 1,419,900 | $39.1M | 8.9% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $36.0M | 8.2% | 00.0% | Unchanged | History |